ZIM
INO icon

Zacks Investment Management’s Inovio Pharmaceuticals INO Stock Holding History

Zacks Investment Management’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.1K Buy
+26,435
New +$31.4K ﹤0.01% 721
2025
Q4 		– Sell
-19,455
Closed -$45.5K – 780
2025
Q3 		$45.5K Buy
+19,455
New +$37.3K ﹤0.01% 733
2019
Q4 		– Sell
-2,866
Closed -$71K – 560
2019
Q3 		$71K Buy
+2,866
New +$87.1K ﹤0.01% 509
2017
Q4 		– Sell
-1,806
Closed -$137K – 608
2017
Q3 		$137K Buy
+1,806
New +$134K ﹤0.01% 558

Other funds holding INO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Zacks Investment Management's INO Position: Q2 2026 in Review

Zacks Investment Management opened a new position in Inovio Pharmaceuticals (INO) in Q2 2026: 26,435 shares worth $29.1K. The stake represents ﹤0.01% of the portfolio and ranks #721 among its holdings. This is a return to the name: Zacks Investment Management previously reported a position in INO as recently as Q3 2025.

Zacks Investment Management first reported a position in INO in Q3 2017 and has held it in 4 quarters since. The position peaked at $137K in Q3 2017. 102 funds tracked by Wall St. Rank hold INO as of Q2 2026.

  • Zacks Investment Management held 26,435 shares of Inovio Pharmaceuticals worth $29.1K as of Q2 2026.
  • Inovio Pharmaceuticals was a new Zacks Investment Management position in Q2 2026.
  • Inovio Pharmaceuticals made up ﹤0.01% of Zacks Investment Management's portfolio in Q2 2026, its #721 holding.
  • Zacks Investment Management first reported a position in Inovio Pharmaceuticals in Q3 2017 and has held it in 4 quarters since.
  • Zacks Investment Management's Inovio Pharmaceuticals position peaked at $137K in Q3 2017.
  • 102 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2026.

Based on Zacks Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.